Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | KDM5A | P29375 | 3/20 | 0.48 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.48 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9807773 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL628762 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL10606558 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL1003342 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL236922 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL24028136 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL14840251 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL2945945 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL21409651 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL4891747 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230249197-A1 | METHOD FOR FLOTATION OF A SILICATE-CONTAINING IRON ORE | BASF S.A. (BR) | 2023-08-10 | — | — | US | disclosed |
| US-11472966-B2 | Coating composition, organic light-emitting diode using same and method for preparing same | LG CHEM, LTD. | 2022-10-18 | — | — | US | disclosed |
| EP-2589701-B1 | METHOD FOR PRODUCING SIZING AGENT-COATED CARBON FIBERS, AND SIZING AGENT-COATED CARBON FIBERS | TORAY INDUSTRIES (JP) | 2019-08-21 | — | — | EP | disclosed |
| US-10184034-B2 | Carbon fiber forming raw material, formed material, and carbon fiber-reinforced composite material | TORAY INDUSTRIES, INC. (JP) | 2019-01-22 | — | — | US | disclosed |
| EP-2765155-B1 | CARBON FIBER-REINFORCED THERMOPLASTIC RESIN MOLDING MATERIAL AND METHODS FOR PRODUCING SAME | TORAY INDUSTRIES (JP) | 2018-03-14 | — | — | EP | disclosed |
| US-9771681-B2 | Method for producing sizing agent-coated carbon fibers, and sizing agent-coated carbon fibers | TORAY INDUSTRIES, INC. (JP) | 2017-09-26 | — | — | US | disclosed |
| CN-103975003-B | Carbon fiber forming blank, moulding material and carbon fibre reinforced composite | 东丽株式会社 | 2017-07-28 | — | — | CN | disclosed |
| US-9593444-B2 | Method for producing sizing agent-coated carbon fibers, and sizing agent-coated carbon fibers | TORAY INDUSTRIES, INC. (JP) | 2017-03-14 | — | — | US | disclosed |
| US-20160230332-A1 | METHOD FOR PRODUCING SIZING AGENT-COATED CARBON FIBERS, AND SIZING AGENT-COATED CARBON FIBERS | TORAY INDUSTRIES, INC. (JP) | 2016-08-11 | — | — | US | disclosed |
| US-9249295-B2 | Carbon fiber-reinforced thermoplastic resin composition, molding material, prepreg, and methods for producing same | TORAY INDUSTRIES, INC. (JP) | 2016-02-02 | — | — | US | disclosed |
| EP-1002786-A1 | Process for the preparation of trifluorobenzoic acids | Clariant GmbH (DE) | 2000-05-24 | — | — | EP | disclosed |
| EP-0757028-B1 | Process for the preparation of aromatic carbonic acid esters | CLARIANT GMBH (DE) | 1999-12-29 | — | — | EP | disclosed |
| EP-0741122-B1 | Process for preparing aromatic compounds through decarboxylation of aromatic carboxylic acids | CLARIANT GMBH (DE) | 1999-08-25 | — | — | EP | disclosed |
| US-5739388-A | Process for the preparation of aromatic compounds by decarboxylation of aromatic carboxylic acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-04-14 | — | — | US | disclosed |
| EP-0811601-A1 | Process for the preparation of aromatic carbonic acid esters | Clariant GmbH (DE) | 1997-12-10 | — | — | EP | disclosed |
| EP-0757028-A1 | Process for the preparation of aromatic carbonic acid esters | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-02-05 | — | — | EP | disclosed |
| CN-1138023-A | Process for preparation of aromatic compounds by decarboxylation of aromatic carboxylic acids | HOECHST AG (DE) | 1996-12-18 | — | — | CN | disclosed |
| EP-0741122-A1 | Process for preparing aromatic compounds through decarboxylation of aromatic carboxylic acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-11-06 | — | — | EP | disclosed |
| EP-0206621-B1 | PROCESS FOR DISPROPORTIONATING SILANES | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-11-15 | — | — | EP | disclosed |
| EP-0206621-A1 | Process for disproportionating silanes | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1986-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11472966-B2 | Coating composition, organic light-emitting diode using same and method for preparing same | OR10J3, SEM1, ORMDL3 | DNM1 2044/4885TSHR 4699/4885THRB 4774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.